Omega Therapeutics Inc (OMGA)
1.795
-0.10
(-5.03%)
USD |
NASDAQ |
Jul 05, 16:00
1.795
0.00 (0.00%)
After-Hours: 18:04
Omega Therapeutics EPS Diluted (Annual): -1.80 for Dec. 31, 2023
EPS Diluted (Annual) Chart
Historical EPS Diluted (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -1.80 |
December 31, 2022 | -2.14 |
December 31, 2021 | -3.05 |
Date | Value |
---|---|
December 31, 2020 | -0.946 |
December 31, 2019 | -0.6925 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Annual) Range, Past 5 Years
-3.05
Minimum
2021
-0.6925
Maximum
2019
-1.726
Average
-1.80
Median
2023
EPS Diluted (Annual) Benchmarks
Altimmune Inc | -1.66 |
Macrogenics Inc | -0.15 |
Viking Therapeutics Inc | -0.91 |
vTv Therapeutics Inc | -9.71 |
Rhythm Pharmaceuticals Inc | -3.20 |